Define the evidence.
Describe the question, the intended use of the data, and what would count as informative evidence. Keep uncertainty and alternative explanations visible.
A question first.
Evidence throughout.
Our scientific direction is to connect therapeutic research with a structured, reviewable approach to research data.
A PROPOSED APPROACH
Keep the biological question in view.
A useful analysis begins with the question it is intended to inform. Our proposed research framework emphasizes context, data quality, and a clear distinction between a computational observation and a development decision.
This is a statement of research direction. It is not a disclosure of a validated target, a named candidate, or an experimental finding.
Document the analysis.
The planned data workflow is intended to retain input descriptions, quality checks, computational settings, and the relationship between outputs and source records.
Interpret with care.
Analysis can inform a research discussion. It does not replace the evidence, oversight, and review relevant to a specific stage of therapeutic development.
Development requires different kinds of evidence.
Drug development encompasses laboratory discovery, preclinical research, clinical research, and regulatory review. These terms describe different activities and evidence requirements; they are not interchangeable.
We do not assign one of those stages to an undisclosed Telemachus program on this website.
General development terminology: FDA — The Drug Development Process ↗. This reference does not imply FDA endorsement or review of Telemachus.
SCIENCE / DATA / COLLABORATIONA thoughtful conversation.
Contact Telemachus